Ibucaps

Ibuprofen, the active ingredient in Ibucaps, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral capsule for oral use. It treats pain, fever and inflammation in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ibucaps as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibucaps, an NSAID, is employed in conditions where inflammation or pain pathways are active.

Pain: Reduces mild to moderate pain such as headache, dental or musculoskeletal discomfort. Fever: Lowers elevated body temperature associated with infections or inflammatory states. Inflammation: Decreases swelling and stiffness in conditions like arthritis or soft‑tissue injury.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer formation. - Severe renal impairment or acute kidney injury. - Anaphylactic or severe allergic reactions. - Hepatotoxicity with elevated liver enzymes. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Thrombotic events in high‑risk patients.

Before using Ibucaps, consider the following precautions: - Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Evaluate renal function: use caution in those with chronic kidney disease. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Monitor elderly patients closely for adverse reactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ibucaps may interact with several medicines; awareness helps prevent complications.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - High‑dose aspirin: additive gastrointestinal toxicity. - Lithium: potential for increased lithium levels.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may reduce renal function. - Diuretics: risk of electrolyte imbalance and renal impairment.